Emcure Pharmaceuticals Ltd
Fortune 500 2025
+ 4 More
+ 4 More
Share
Share
OVERVIEW
FINANCIALS
NEWS
Featured In Fortune India Ranking
Fortune 500 India
#313(2025)
#345(2023)
#282(2022)
#220(2021)
#313(2025)#345(2023)#282(2022)#220(2021)
Next 500 India
#4(2015)
#4(2015)
Financial Data 2024
Revenue
6,905
(INR Cr)
Net Operating Income
6,658
(INR Cr)
Assets
5,811
(INR Cr)
Profit
498
(INR Cr)
Net Worth
2,952
(INR Cr)
Fortune India Coverage
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 6905 15.8% | 5965 -1.6% | 6064 12.9% | 5371 4.7% | 5129 1.7% | 5044 19.2% | 4233 97.4% | 2144 -6.0% | 2280 9.1% | 2090 24.2% | 1683 23.1% | 1368 -26.9% | 1872 36.4% | 1372 12.6% | 1219 48.4% | 822 - |
| Net Operating Income (INR Cr) | 6658 11.23% | 5986 2.23% | 5855 16.33% | 5033 -0.30% | 5049 7.02% | 4717 11.58% | 4228 0.00% | 2058 -3.90% | 2141 5.44% | 2031 24.71% | 1629 25.20% | 1301 6.00% | 1804 33.69% | 1350 28.04% | 1054 27.25% | 828 27.94% |
| Profit (INR Cr) | 498 -6.4% | 532 -19.7% | 662 58.2% | 419 400.7% | 84 -57.1% | 195 11.4% | 175 -19.4% | 217 -25.6% | 292 41.3% | 207 18.5% | 174 80.6% | 97 0.9% | 96 16.3% | 82 -58.4% | 198 - | -148 - |
| Assets (INR Cr) | 5811 14.2% | 5089 14.5% | 4445 -10.5% | 4966 6.0% | 4686 4.7% | 4474 9.4% | 4090 78.8% | 2287 13.7% | 2011 27.3% | 1579 8.6% | 1455 14.3% | 1272 -14.1% | 1482 36.8% | 1083 19.7% | 904 1.7% | 889 - |
| Net Worth (INR Cr) | 2952 18.0% | 2501 25.8% | 1988 -12.6% | 2273 18.9% | 1912 4.2% | 1835 7.9% | 1701 0.0% | 1227 18.4% | 1036 20.6% | 859 17.3% | 732 21.9% | 601 16.1% | 514 17.6% | 437 24.8% | 350 109.8% | 167 -46.4% |
| Employee Cost (INR Cr) | 1292 15.6% | 1117 10.4% | 1012 12.1% | 903 -18.3% | 1106 9.4% | 1010 13.9% | 887 90.6% | 466 11.3% | 419 22.1% | 343 19.6% | 287 23.8% | 232 -29.2% | 327 29.6% | 253 41.1% | 179 22.5% | 146 - |
| Interest Cost (INR Cr) | 237 | 214 | 176 | 155 | 257 | 223 | 176 | 100 | 114 | 78 | 76 | 65 | 74 | 52 | 35 | 32 |
| Cash & Bank Balance (INR Cr) | 232 | 458 | 313 | 524 | 164 | 104 | 270 | 17 | 28 | 32 | 70 | 10 | 46 | 21 | 21 | 10 |
| Total Debt (INR Cr) | 2335 | 2334 | 2217 | 2310 | 2327 | 2128 | 1988 | 1035 | 951 | 671 | 678 | 611 | 698 | 526 | 410 | 416 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 7.2% | 8.9% | 10.9% | 7.8% | 1.6% | 3.9% | 4.1% | 10.1% | 12.8% | 9.9% | 10.4% | 7.1% | 5.1% | 6.0% | 16.2% | - |
| Profit As % Of Assets | 8.6% | 10.5% | 14.9% | 8.4% | 1.8% | 4.4% | 4.3% | 9.5% | 14.5% | 13.1% | 12.0% | 7.6% | 6.5% | 7.6% | 21.9% | - |
| Profit As % Of Networth | 16.9% | 21.3% | 33.3% | 18.4% | 4.4% | 10.6% | 10.3% | 17.7% | 28.2% | 24.1% | 23.8% | 16.1% | 18.6% | 18.9% | 56.5% | - |
| Interest Cost to EBITDA % | 19.4% | 18.2% | 13.2% | 15.1% | 42.7% | 35.6% | 27.1% | 24.9% | 21.7% | 23.1% | 23.8% | 32.3% | 25.0% | 23.5% | 16.3% | - |
| Debt to Equity Ratio | 0.79 | 0.93 | 1.12 | 1.02 | 1.22 | 1.16 | 1.17 | 0.84 | 0.92 | 0.78 | 0.93 | 1.02 | 1.36 | 1.20 | 1.17 | 2.50 |
| RONW | 19.4% | 25.0% | 33.0% | 20.1% | 9.4% | 11.8% | 14.3% | 19.2% | 30.8% | 44.0% | 26.2% | 14.3% | 21.1% | 22.0% | 18.7% | - |
| ROCE | 18.2% | 20.8% | 25.0% | 21.1% | 10.4% | 13.1% | 14.5% | 15.1% | 26.3% | 30.6% | 20.3% | 13.5% | 15.7% | 17.5% | 19.7% | 0.0% |